Here we demonstrated an important novel role for RFX1 in the regulation of the increased IL-17A expression in CD4+ T cells of patients with SLE, as well as in the differentiation of Th17 cells and the development of the IL-17-related autoimmune diseases EAE and lupus in mice. Here, CD4 is linked to autoimmune disease.